Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Rural risk environments for hepatitis c among young adults in appalachian kentucky.

Tytuł :
Rural risk environments for hepatitis c among young adults in appalachian kentucky.
Autorzy :
Cloud DH; Emory University, Rollins School of Public Health, United States. Electronic address: .
Ibragimov U; Emory University, Rollins School of Public Health, United States.
Prood N; Emory University, Rollins School of Public Health, United States.
Young AM; University of Kentucky College of Public Health, United States.
Cooper HLF; Emory University, Rollins School of Public Health, United States.
Pokaż więcej
Źródło :
The International journal on drug policy [Int J Drug Policy] 2019 Oct; Vol. 72, pp. 47-54. Date of Electronic Publication: 2019 May 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
Język :
English
Imprint Name(s) :
Publication: 1998- : Amsterdam ; New York : Elsevier
Original Publication: Liverpool, England : International Journal on Drug Policy,
MeSH Terms :
Harm Reduction*
Rural Population*
Hepatitis C/*epidemiology
Substance Abuse, Intravenous/*complications
Adult ; Appalachian Region ; Female ; Hepatitis C/transmission ; Humans ; Interviews as Topic ; Kentucky/epidemiology ; Male ; Risk-Taking ; Substance Abuse, Intravenous/epidemiology ; Young Adult
References :
Int Arch Occup Environ Health. 2009 Jan;82(2):243-9. (PMID: 18461350)
Annu Rev Public Health. 2016;37:167-84. (PMID: 26735428)
Am J Public Health. 2011 Feb;101(2):344-9. (PMID: 21164088)
AIDS Behav. 2013 Sep;17(7):2341-51. (PMID: 23184464)
JAMA Intern Med. 2016 Oct 1;176(10):1501-1509. (PMID: 27532694)
Int J Drug Policy. 2009 May;20(3):193-201. (PMID: 19147339)
Am J Public Health. 2011 Nov;101(11):2012-5. (PMID: 21940924)
BMJ. 2014 Nov 06;349:g6605. (PMID: 25376623)
JAMA Psychiatry. 2014 Jul 1;71(7):821-6. (PMID: 24871348)
J Urban Health. 2003 Jun;80(2):330-48. (PMID: 12791808)
Health Place. 2012 Mar;18(2):218-28. (PMID: 22047790)
Int J Drug Policy. 2018 Feb;52:97-101. (PMID: 29278838)
North Am Dialogue. 2016 Fall;19(2):70-84. (PMID: 28736509)
J Rural Health. 2019 Jan;35(1):97-107. (PMID: 29664203)
Am J Epidemiol. 2017 Oct 15;186(8):970-978. (PMID: 28535162)
Int J Drug Policy. 2016 Nov;37:1-8. (PMID: 27449813)
Int J Drug Policy. 2016 Mar;29:19-26. (PMID: 26868674)
Int J Drug Policy. 2014 May;25(3):503-7. (PMID: 24746862)
Rural Ment Health. 2017 Apr;41(2):123-135. (PMID: 29057030)
Int J Drug Policy. 2017 Aug;46:1-6. (PMID: 28511053)
Med Care. 2017 Apr;55(4):336-341. (PMID: 28296674)
Int J Drug Policy. 2009 May;20(3):217-26. (PMID: 18963907)
Drug Alcohol Depend. 2011 May 1;115(1-2):107-12. (PMID: 21126831)
Int J Drug Policy. 2016 Jan;27:56-64. (PMID: 26530884)
Int J Drug Policy. 2016 Jun;32:11-6. (PMID: 27198555)
Epidemiol Infect. 2013 Feb;141(2):402-11. (PMID: 22717190)
MMWR Morb Mortal Wkly Rep. 2016 Jul 22;65(28):705-10. (PMID: 27442053)
Ann Epidemiol. 2016 Sep;26(9):619-630.e2. (PMID: 27576908)
Public Health Rep. 2010 Jan-Feb;125(1):121-8. (PMID: 20402204)
Addiction. 2012 Mar;107(3):587-96. (PMID: 21883604)
Harm Reduct J. 2010 Oct 15;7:24. (PMID: 20950455)
Adv Prev Med. 2013;2013:346372. (PMID: 23840957)
Arch Sex Behav. 2017 May;46(4):925-936. (PMID: 26927277)
Drug Alcohol Depend. 2016 Mar 1;160:30-41. (PMID: 26781062)
Drug Alcohol Depend. 2014 Nov 1;144:265-9. (PMID: 25193720)
Int J Drug Policy. 2016 Jan;27:43-55. (PMID: 26342272)
Soc Sci Med. 2012 May;74(10):1602-9. (PMID: 22465379)
Am J Public Health. 2018 Feb;108(2):175-181. (PMID: 29267061)
J Health Polit Policy Law. 2017 Aug;42(4):719-737. (PMID: 28483807)
MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453-8. (PMID: 25950251)
Int J Drug Policy. 2009 May;20(3):283-91. (PMID: 19101131)
Soc Work Public Health. 2015;30(4):385-96. (PMID: 25950907)
Lancet. 2010 Jul 24;376(9737):268-84. (PMID: 20650523)
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331. (PMID: 27763996)
Int J Drug Policy. 2014 May;25(3):556-61. (PMID: 24411945)
Curr HIV/AIDS Rep. 2018 Apr;15(2):113-119. (PMID: 29457200)
Grant Information :
R21 DA042727 United States DA NIDA NIH HHS; UG3 DA044798 United States DA NIDA NIH HHS
Contributed Indexing :
Keywords: Hepatitis C*; Kentucky*; Opioid*; Risk environment*; Rural*
Entry Date(s) :
Date Created: 20190523 Date Completed: 20200520 Latest Revision: 20201001
Update Code :
20201218
PubMed Central ID :
PMC7335461
DOI :
10.1016/j.drugpo.2019.05.006
PMID :
31113713
Czasopismo naukowe
Background: Rural Kentucky is an epicenter of hepatitis C(HCV), especially among young adults who inject drugs. While the Risk Environment Framework (REF) has been used widely to study and address socio-ecological determinants of infectious disease among people who inject drugs (PWID), it has been almost exclusively applied to urban environments. Applying REF to rural environments can enhance our understanding of the drivers of HCV epidemics in these hard-hit areas, and inform the creation and implementation of harm reduction interventions in this local context.
Methods: Participants were recruited between March and August 2017 via community-based outreach methods (e.g., cookouts, flyers) and peer referral. Individuals who met eligibility criteria (aged 18-35, recently used prescription opioids and/or heroin to get high, lived in one of the 5 target counties) participated indepth, semi-structured interviews. The interview guide was informed by the REF, and covered HCV-related risk behaviors and environmental features that shaped vulnerability to engaging in these behaviors. Interviews were transcribed and analyzed using constructivist grounded-theory methods.
Results: Participants (N=19) described multiple intersecting risk environment features that shaped vulnerability to HCV transmission. Economic decline generated intergenerational poverty, dwindling employment prospects, and diminished social enrichment opportunities that collectively contributed to substance misuse and risky injection practices. Geographic isolation, lack of collective knowledge about HCV transmission risks, scarce harm reduction services, familial poverty, and fear of law enforcement interacted to increase the odds of people injecting in "trap houses" (akin to shooting galleries) or secluded areas, spaces in which they rushed to inject and shared injection equipment. Pervasive stigma was a structural barrier to adopting, expanding, and using harm reduction services.
Conclusion: This exploratory study identified features of rural risk environments that may contribute to significant HCV burdens in Appalachian Kentucky. Findings signal the importance of expanding proven harm reduction strategies and anti-stigma interventions tailored to rural contexts.
(Copyright © 2019 Elsevier B.V. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies